ArticleAsian journal of andrology2024
PSA as the driving biomarker to manage low- and intermediate-risk prostate cancer patients in clinical practice.
Enrico Ricevuto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it